Logo

In the News

2022

February 24, 2022
Exploring Cell Therapy for the Treatment of Drug-Resistant Epilepsy

2021

November 9, 2021
Promising new approach for people with epilepsy

November 9, 2021
Focal Epilepsy Cell Therapy NRTX-1001 Gets IND Clearance, Set to Begin Phase 1/2 Trial

September 24, 2021
A Mind For Medicine. Researchers are tapping into the regenerative power of stem cells to treat central nervous system disorders.

June 23, 2021
Neurona Therapeutics is dashing to the clinic with its cell therapy for epilepsy — but first, another venture round

May 19, 2021
Transplanting Specialized Neurons Cory R Nicholas, PhD, Co-Founder and CEO of Neurona Therapeutics, talks to Pharmafile about the world of neurological disorders and transplantation. (This article is taken from Pharmafile Spring 2021, pages 54-55. © Samedan Ltd)

2016-2009

September 22, 2016
Human Neuron Transplants Treat Spinal Cord Injury in Mice

May 4, 2015
The Daily Startup: How This VC Firm is Building Its Own Biotech Companies

December 24, 2014
Stem cells to transplant in the brain: Stealth UCSF spinout Neurona Therapeutics raises $7.6M

May 07, 2013
Successful transplantation of lab-derived interneurons in mice

May 07, 2013
Epileptic mice cured with transplantation of MGE interneurons

June 21, 2012
Reining in pain

September 10, 2009
Progenitor cell therapy for epilepsy

  • About
    • Mission / Vision
    • Leadership
    • Board of Directors
    • Scientific Advisors
    • Investors
  • Technology
    • Approach
    • Manufacturing
    • Publications
  • Pipeline
    • Programs
  • Clinical Trials
    • Phase I/II: NRTX-1001 for epilepsy
  • News
    • Press Releases
      • 061722
      • 052622
      • 040422
      • 040122
      • 010522
      • 121321
      • 120321
      • 111821
      • 110821
      • 110421
      • 102022
      • 062221
      • 061621
      • 041921
      • 103119
      • 121417
      • 120117
    • In the News
    • Events
  • Careers
    • Culture
    • Values
    • Benefits
    • Visiting Scientists & Internship programs
    • Job Opportunities
  • Contact
  • Home
  • About
    • Mission / Vision
    • Leadership
    • Board of Directors
    • Scientific Advisors
    • Investors
  • Technology
    • Approach
    • Manufacturing
    • Publications
  • Pipeline
    • Programs
  • Clinical Trials
    • Phase I/II: NRTX-1001 for epilepsy
  • News
    • Press Releases
      • 061722
      • 052622
      • 040422
      • 040122
      • 010522
      • 121321
      • 120321
      • 111821
      • 110821
      • 110421
      • 102022
      • 062221
      • 061621
      • 041921
      • 103119
      • 121417
      • 120117
    • In the News
    • Events
  • Careers
    • Culture
    • Values
    • Benefits
    • Visiting Scientists & Internship programs
    • Job Opportunities
  • Contact
Logo
Neurona Therapeutics
170 Harbor Way
South San Francisco, CA 94080
info@neuronatx.com
LinkedIn
© 2022 Neurona Therapeutics All rights reserved.
  • Terms of Use
  • Privacy Policy
Website Design: Hane Chow, Inc.